|
contents | america | ||||
| MASS Opportunities Conference The Massachusetts Biotechnology Council's (MBC) annual MASSOpportunities biotechnology investment conference and partnering forum, will showcase over 50 public and private companies, as well as industry and academic leaders, on panels, roundtables and in company presentations. MASS Opportunities, New England's largest biotechnology investor forum, will take place on November 2. The one-day conference will feature presentations from private companies such as BioVex, Cambria Biosciences, ProNai and Sirtris Pharmaceuticals, as well as public companies including, Acambis, ArQule, Coley Pharmaceutical Group, and Momenta Pharmaceuticals. Panels and roundtables at the conference will explore a number of trends driving new company formation and new product discovery and development. write your comments about the article :: © 2006 Exhibition News :: home page |